BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The biggest challenges facing targeted radiopharmaceuticals ar
 e the highly complex processes associated with acquiring raw radioisotope
  APIs\, the limited availability of these radionuclides\, and getting who
 le-drug products to patients on time. This can't be done alone! Abdera\, 
 Clarity\, and Rayze have all recently landed landmark supply deals to fue
 l their clinical development and there are certainly more to come!\n\nThe
  Targeted Radiopharmaceuticals Manufacturing and Supply Chain Summit is t
 he only industry-led meeting dedicated to plugging the gaps in radioisoto
 pe supply by developing new sources\, designing manufacturing facilities 
 that are scalable\, and ensuring safety and quality through well-tested r
 elease criteria for whole drug products.\n\nJoin us as we unite 80+ key s
 takeholders in CMC\, quality assurance\, operations\, facility managers\,
  and radiopharmacists to bring the targeted radiotherapies to the forefro
 nt of cancer treatment.\n\nCapitalizing on the recent successes this spac
 e had over the last year\, there has never been this amount of demand and
  excitement for the TRP community. Take advantage of this platform to hea
 r in-depth challenges and solutions in the global TRP manufacturing lands
 cape.\n\nURLs:Brochure:&nbsp\;https://go.evvnt.com/1729138-1?pid=185Ticke
 ts:&nbsp\;https://go.evvnt.com/1729138-2?pid=185Tickets:&nbsp\;https://go
 .evvnt.com/1729138-3?pid=185\n\nPrices:Drug Developer Pricing Conference 
 + 2 Workshops: USD 4297.00\,Drug Developer Pricing Conference + 1 Worksho
 p: USD 3648.00\,Drug Developer Pricing Conference Only: USD 2999.00\,Solu
 tion Providers- Conference + 2 Workshops: USD 5297.00\,Solution Providers
 - Conference + 1 Workshop: USD 4548.00\,Solution Providers- Conference On
 ly: USD 3799.00\n\nSpeakers:&nbsp\;Anna Kulesza Director - Chemistry\, Ma
 nufacturing and Controls &nbsp\;Clovis Oncology\, Dan Saragnese Head of M
 anufacturing &nbsp\;Earli Inc.\, Diane Abou\, Assistant Professor at Wash
 ington University in ST. Louis and Lead Chemist at Curium &nbsp\;Washingt
 on University School of Medicine\, Eric Burak Chief Technical Officer &nb
 sp\;Fusion Pharmaceuticals\, Geoffrey Johnson Chair of Nuclear Medicine &
 nbsp\;Mayo Clinic\, Giuseppe Carlucci Director UCLA Biomedical Cyclotron 
 &nbsp\;University of California Los Angeles\, Izabela Tworowska Chief Tec
 hnology Officer &nbsp\;Radiomedix Inc\, Jarrod Longcor Chief Operating Of
 ficer &nbsp\;Cellectar Biosciences Inc.\, Kemp Dolliver Director of Resea
 rch and Senior Analyst &nbsp\;Brookline Capital Markets\, Kevin Roland Vi
 ce-President Radiopharmaceuticals manufacturing &nbsp\;Fusion Pharmaceuti
 cals\, Michael Nickels Director - Cyclotron Facility &nbsp\;Washington Un
 iversity School of Medicine\, Roland Turck Managing Partner &nbsp\;TurckB
 io\, Shaemus Gleason Executive Vice President &nbsp\;Clarity Pharmaceutic
 als\, Shankar Vallabhajosula Scientific Advisor &nbsp\;Convergent Therape
 utics\, Thomas Birger Eden-Jensen Head of Product Supply Operations &nbsp
 \;Bayer\, Vishnu Dwadasi Director - Manufacturing &nbsp\;Ashvattha Therap
 eutics\, Ying Cai Director - Supply Chain &nbsp\;Ashvattha Therapeutics\n
 \nTime:&nbsp\;9:00 am to 5:00 pm\n
DTEND:20230928T170000
DTSTAMP:20260512T223116Z
DTSTART:20230926T090000
LOCATION:Hilton Boston Back Bay\, 40\, Dalton Street\, Boston\, Massachuse
 tts\, 02115\,
SEQUENCE:0
SUMMARY:The biggest challenges facing targeted radiopharmaceuticals are th
 e highly complex processes associated with acquiring raw radioisotope API
 s\, the l...
UID:f2aaa0cc-7347-410b-97ac-4acb5400c135
END:VEVENT
END:VCALENDAR